Theralase Technologies Inc
XTSX:TLT
Theralase Technologies Inc
XTSX:TLT
Price:
0.165 CAD
3.13%
Market Closed
Updated:
May 7, 2024
Section:
Relative Value
The Relative Value of one
TLT
stock under the Base Case scenario is
0.314
CAD.
Compared to the current market price of 0.165 CAD,
Theralase Technologies Inc
is
Undervalued by 47%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TLT
Relative Value
Base Case
0.314
CAD
Undervaluation 47%
Valuation Multiples
Multiples Across Competitors
TLT Competitors Multiples
Theralase Technologies Inc Competitors
Theralase Technologies Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Theralase Technologies Inc
XTSX:TLT
|
37.7m CAD | 35.2 | -8.2 | -8.7 | -8.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.2B USD | 4.5 | 32.5 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.9B USD | 18.6 | 68.4 | 56.1 | 70.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124B USD | 5.9 | 36.9 | 24 | 29.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.7B USD | 3.4 | 25.9 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.3B USD | 7.2 | 60.2 | 30.7 | 45.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.3B USD | 3.5 | 56.1 | 18.8 | 39.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.5B EUR | 2.7 | 38.6 | 18.5 | 31.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
378.2B CNY | 11 | 33.4 | 29.1 | 29.1 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.4B USD | 13.5 | 80.3 | 60 | 78.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | 36.2 | 26.3 | 28.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
